Cargando…
A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA(2)-Asp-49 from Bothrops jararacussu Venom
Phospholipases A(2) (PLA(2)) represent a superfamily of enzymes widely distributed in living organisms, with a broad spectrum of pharmacological activities and therapeutic potential. Anti-angiogenic strategies have become one of the main tools in fighting cancer. In this sense, the present work repo...
Autores principales: | Van Petten de Vasconcelos Azevedo, Fernanda, Lopes, Daiana Silva, Zóia, Mariana Alves Pereira, Correia, Lucas Ian Veloso, Saito, Natieli, Fonseca, Belchiolina Beatriz, Polloni, Lorena, Teixeira, Samuel Cota, Goulart, Luiz Ricardo, de Melo Rodrigues Ávila, Veridiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961627/ https://www.ncbi.nlm.nih.gov/pubmed/35204758 http://dx.doi.org/10.3390/biom12020258 |
Ejemplares similares
-
Linear B-cell epitopes in BthTX-I, BthTX-II and BthA-I, phospholipase A(2's )from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom
por: De-Simone, Salvatore, et al.
Publicado: (2014) -
BthTX-I from Bothrops jararacussu induces apoptosis
in human breast cancer cell lines and decreases cancer stem cell
subpopulation
por: Bezerra, Patrícia Heloise Alves, et al.
Publicado: (2019) -
Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines
por: Prinholato da Silva, Cássio, et al.
Publicado: (2015) -
Antibacterial Activity of the Non-Cytotoxic Peptide (p-BthTX-I)(2) and Its Serum Degradation Product against Multidrug-Resistant Bacteria
por: Santos-Filho, Norival A., et al.
Publicado: (2017) -
Effects of Dimerization, Dendrimerization, and Chirality in p-BthTX-I Peptide Analogs on the Antibacterial Activity and Enzymatic Inhibition of the SARS-CoV-2 PL(pro) Protein
por: Bitencourt, Natália Vitória, et al.
Publicado: (2023)